CHCHD2 and Parkinson disease: To achieve this goal, we further examined CHCHD2 mRNA in erythrocytes of individual PD patients in a cohort of 340 subjects including patients with early- (n = 73), middle- (n = 98), and late-stage PD (n = 34) along with controls (n = 135).